Kenichi Arai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kenichi Arai has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Koichi Nakayama
Center for Regenerative Medicine Research, Faculty of Medicine, Saga University, Honjo-machi, Saga, Saga, Saga, 840-8502, JAPAN
2 shared publications- Makoto Nakamura
University of Toyama
2 shared publications - Shintaroh Iwanaga
Division of Biomedical System Engineering, Graduate School of Science and Engineering for Education, University of Toyama, 3190 Gofuku, Toyama 930-8555, Japan
2 shared publications Takahiro Kitsuka
Department of Cardiovascular Medicine, Faculty of medicine, Saga University, Honjo-machi, Saga, Saga, Saga, 840-8502, JAPAN
2 shared publications- Tanveer Ahmad Mir
Laboratory of Tissue/Organ Bioengineering and BioMEMS, Organ Transplant Centre of Excellence, Transplantation Research & Innovation (Dpt)-R, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia
2 shared publications - Abdullah Altuhami
King Faisal Specialist Hospital and Research Centre
1 shared publication
Latest Publications
- Open Access
- 31 July 2026
- Published by Scifiniti Publishing in Biomaterials Connect
- Vol. 3 (1) , 1-10
Importance of Cell Alignment in Cardiac Tissue Engineering
Native myocardium is a structurally anisotropic and electromechanically integrated tissue in which cardiomyocytes, extracellular matrix fibers, vascular structures, and conduction pathways are organized across multiple length scales. A key feature of this architecture is not a simple stack of discrete layers with slight misalignment, but a continuous transmural variation in predominant myofiber angle from the endocardial to the epicardial surface. This organization supports anisotropic electrical propagation, regional deformation, ventricular torsion, wall thickening, and efficient blood ejection. Conventional two-dimensional culture systems often produce randomly oriented and immature cardiomyocytes, limiting their ability to reproduce native myocardial mechanics or disease-associated remodeling. This narrative review revises and expands the discussion of cardiomyocyte alignment in cardiac tissue engineering, with emphasis on nanofiber-based scaffolds, electrospinning, biomaterial selection, electrical stimulation, mechanical conditioning, bioprinting, and vascularization strategies. We compare spheroids, organoids, conventional scaffolds, aligned nanofibers, three-dimensional bioprinting, and biophysical stimulation approaches in terms of alignment mechanism, maturation readouts, advantages, limitations, and translational challenges. Particular attention is given to scaffold design parameters, including fiber diameter, degree of alignment, porosity, stiffness, degradation behavior, conductivity, surface functionalization, and extracellular matrix coating. We also discuss why alignment strategies should be adapted to the target ventricular region, because left and right ventricular myocardium differ in geometry, loading condition, fiber architecture, and contractile pattern. Finally, we highlight remaining barriers to clinical translation, including vascularization, oxygen and nutrient diffusion, host-tissue electrical integration, arrhythmia risk, scalability, reproducibility, and standardized functional assessment.
- 31 July 2026
- Published by Scifiniti Publishing in Biomaterials Connect
- Vol. 3 (1) , 1-10
Open AccessImportance of Cell Alignment in Cardiac Tissue Engineering
Native myocardium is a structurally anisotropic and electromechanically integrated tissue in which cardiomyocytes, extracellular matrix fibers, vascular structures, and conduction pathways are organized across multiple length scales. A key feature of this architecture is not a simple stack of discrete layers with slight misalignment, but a continuous transmural variation in predominant myofiber angle from the endocardial to the epicardial surface. This organization supports anisotropic electrical propagation, regional deformation, ventricular torsion, wall thickening, and efficient blood ejection. Conventional two-dimensional culture systems often produce randomly oriented and immature cardiomyocytes, limiting their ability to reproduce native myocardial mechanics or disease-associated remodeling. This narrative review revises and expands the discussion of cardiomyocyte alignment in cardiac tissue engineering, with emphasis on nanofiber-based scaffolds, electrospinning, biomaterial selection, electrical stimulation, mechanical conditioning, bioprinting, and vascularization strategies. We compare spheroids, organoids, conventional scaffolds, aligned nanofibers, three-dimensional bioprinting, and biophysical stimulation approaches in terms of alignment mechanism, maturation readouts, advantages, limitations, and translational challenges. Particular attention is given to scaffold design parameters, including fiber diameter, degree of alignment, porosity, stiffness, degradation behavior, conductivity, surface functionalization, and extracellular matrix coating. We also discuss why alignment strategies should be adapted to the target ventricular region, because left and right ventricular myocardium differ in geometry, loading condition, fiber architecture, and contractile pattern. Finally, we highlight remaining barriers to clinical translation, including vascularization, oxygen and nutrient diffusion, host-tissue electrical integration, arrhythmia risk, scalability, reproducibility, and standardized functional assessment.
- Open Access
- 26 March 2024
- Published by Elsevier in Regenerative Therapy
- Vol. 27, 170-180
Transplanted artificial amnion membrane enhanced wound healing in third-degree burn injury diabetic mouse model
- 26 March 2024
- Published by Elsevier in Regenerative Therapy
- Vol. 27, 170-180
Open AccessTransplanted artificial amnion membrane enhanced wound healing in third-degree burn injury diabetic mouse model
- Open Access
- 25 September 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (10) , 1126
Whole Liver Derived Acellular Extracellular Matrix for Bioengineering of Liver Constructs: An Updated Review
Biomaterial templates play a critical role in establishing and bioinstructing three-dimensional cellular growth, proliferation and spatial morphogenetic processes that culminate in the development of physiologically relevant in vitro liver models. Various natural and synthetic polymeric biomaterials are currently available to construct biomimetic cell culture environments to investigate hepatic cell–matrix interactions, drug response assessment, toxicity, and disease mechanisms. One specific class of natural biomaterials consists of the decellularized liver extracellular matrix (dECM) derived from xenogeneic or allogeneic sources, which is rich in bioconstituents essential for the ultrastructural stability, function, repair, and regeneration of tissues/organs. Considering the significance of the key design blueprints of organ-specific acellular substrates for physiologically active graft reconstruction, herein we showcased the latest updates in the field of liver decellularization–recellularization technologies. Overall, this review highlights the potential of acellular matrix as a promising biomaterial in light of recent advances in the preparation of liver-specific whole organ scaffolds. The review concludes with a discussion of the challenges and future prospects of liver-specific decellularized materials in the direction of translational research.
- 25 September 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (10) , 1126
Open AccessWhole Liver Derived Acellular Extracellular Matrix for Bioengineering of Liver Constructs: An Updated Review
Biomaterial templates play a critical role in establishing and bioinstructing three-dimensional cellular growth, proliferation and spatial morphogenetic processes that culminate in the development of physiologically relevant in vitro liver models. Various natural and synthetic polymeric biomaterials are currently available to construct biomimetic cell culture environments to investigate hepatic cell–matrix interactions, drug response assessment, toxicity, and disease mechanisms. One specific class of natural biomaterials consists of the decellularized liver extracellular matrix (dECM) derived from xenogeneic or allogeneic sources, which is rich in bioconstituents essential for the ultrastructural stability, function, repair, and regeneration of tissues/organs. Considering the significance of the key design blueprints of organ-specific acellular substrates for physiologically active graft reconstruction, herein we showcased the latest updates in the field of liver decellularization–recellularization technologies. Overall, this review highlights the potential of acellular matrix as a promising biomaterial in light of recent advances in the preparation of liver-specific whole organ scaffolds. The review concludes with a discussion of the challenges and future prospects of liver-specific decellularized materials in the direction of translational research.
- Open Access
- 10 February 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (2) , 237
The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
Induced pluripotent stem cells (iPSCs) have become a prevalent topic after their discovery, advertised as an ethical alternative to embryonic stem cells (ESCs). Due to their ability to differentiate into several kinds of cells, including cardiomyocytes, researchers quickly realized the potential for differentiated cardiomyocytes to be used in the treatment of heart failure, a research area with few alternatives. This paper discusses the differentiation process for human iPSC-derived cardiomyocytes and the possible applications of said cells while answering some questions regarding ethical issues.
- 10 February 2023
- Published by MDPI AG in Bioengineering
- Vol. 10 (2) , 237
Open AccessThe Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
Induced pluripotent stem cells (iPSCs) have become a prevalent topic after their discovery, advertised as an ethical alternative to embryonic stem cells (ESCs). Due to their ability to differentiate into several kinds of cells, including cardiomyocytes, researchers quickly realized the potential for differentiated cardiomyocytes to be used in the treatment of heart failure, a research area with few alternatives. This paper discusses the differentiation process for human iPSC-derived cardiomyocytes and the possible applications of said cells while answering some questions regarding ethical issues.
- Open Access
Design and Fabrication of Mature Engineered Pre-Cardiac Tissue Utilizing 3D Bioprinting Technology and Enzymatically Crosslinking Hydrogel
The fabrication of mature engineered cardiac tissue is one of the major challenges in cardiac tissue engineering. For this purpose, we attempted to apply the 3D bioprinting approach. Aiming to construct an oriented tissue, a fine fiber-shaped scaffold with a support structure was first designed using CAD software. Then, a 3D bioprinter and cell-adhesive bio-inks were utilized to fabricate this structure. The cell-adhesive bio-inks were synthesized by combining sodium alginate and gelatin with tyramine, respectively, to form pre-gel materials that allow enzymatic crosslinking by horseradish peroxidase. By absorbance measurements, we confirmed that the tyramine modification rate of each polymer was 0.535 mmol/g-alginate and 0.219 mmol/g-gelatin. The width of the fiber-shaped scaffold was 216.8 ± 24.3 μm for the fabricated scaffold, while the design value was 200 μm. After 3D printing and adhesion-adding treatment of the scaffold with these bio-ink materials, cardiomyocytes were seeded and cultured. As a result, the cells spread onto the scaffold, and the entire pre-tissue contracted synchronously by day 6 of culture, showing a greater pulsatility than in the early days. Video analysis showed that the beating rate of pre-myocardial tissue on day 6 was 31 beats/min. In addition, we confirmed that the cardiomyocytes partially elongated along the long axis of the fiber-shaped scaffold in the pre-tissue cultured for 15 days by staining actin, suggesting the possibility of cell orientation. Furthermore, treatment with adrenaline resulted in a 7.7-fold increase in peak beating rate compared to that before treatment (from 6 beats/min to 46 beats/min), confirming the responsiveness of the pre-tissues to the drug. These results indicate that 3D bioprinting effectively produces mature cultured myocardial tissue that is oriented, contracts synchronously, and is responsive to drugs.
Open AccessDesign and Fabrication of Mature Engineered Pre-Cardiac Tissue Utilizing 3D Bioprinting Technology and Enzymatically Crosslinking Hydrogel
The fabrication of mature engineered cardiac tissue is one of the major challenges in cardiac tissue engineering. For this purpose, we attempted to apply the 3D bioprinting approach. Aiming to construct an oriented tissue, a fine fiber-shaped scaffold with a support structure was first designed using CAD software. Then, a 3D bioprinter and cell-adhesive bio-inks were utilized to fabricate this structure. The cell-adhesive bio-inks were synthesized by combining sodium alginate and gelatin with tyramine, respectively, to form pre-gel materials that allow enzymatic crosslinking by horseradish peroxidase. By absorbance measurements, we confirmed that the tyramine modification rate of each polymer was 0.535 mmol/g-alginate and 0.219 mmol/g-gelatin. The width of the fiber-shaped scaffold was 216.8 ± 24.3 μm for the fabricated scaffold, while the design value was 200 μm. After 3D printing and adhesion-adding treatment of the scaffold with these bio-ink materials, cardiomyocytes were seeded and cultured. As a result, the cells spread onto the scaffold, and the entire pre-tissue contracted synchronously by day 6 of culture, showing a greater pulsatility than in the early days. Video analysis showed that the beating rate of pre-myocardial tissue on day 6 was 31 beats/min. In addition, we confirmed that the cardiomyocytes partially elongated along the long axis of the fiber-shaped scaffold in the pre-tissue cultured for 15 days by staining actin, suggesting the possibility of cell orientation. Furthermore, treatment with adrenaline resulted in a 7.7-fold increase in peak beating rate compared to that before treatment (from 6 beats/min to 46 beats/min), confirming the responsiveness of the pre-tissues to the drug. These results indicate that 3D bioprinting effectively produces mature cultured myocardial tissue that is oriented, contracts synchronously, and is responsive to drugs.
- 22 July 2021
- Published by IOP Publishing in Biofabrication
- Vol. 13 (4) , 042001
Scaffold-based and scaffold-free cardiac constructs for drug testing
The safety and therapeutic efficacy of new drugs are tested in experimental animals. However, besides being a laborious, costly process, differences in drug responses between humans and other animals and potential cardiac adverse effects lead to the discontinued development of new drugs. Thus, alternative approaches to animal tests are needed. Cardiotoxicity and responses of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to drugs are conventionally evaluated by cell seeding and two-dimensional (2D) culture, which allows measurements of field potential duration and the action potentials of CMs using multielectrode arrays. However, 2D-cultured hiPSC-CMs lack 3D spatial adhesion, and have fewer intercellular and extracellular matrix interactions, as well as different contractile behavior from CMs in vivo . This issue has been addressed using tissue engineering to fabricate three-dimensional (3D) cardiac constructs from hiPSC-CMs cultured in vitro . Tissue engineering can be categorized as scaffold-based and scaffold-free. In scaffold-based tissue engineering, collagen and fibrin gel scaffolds comprise a 3D culture environment in which seeded cells exhibit cardiac-specific functions and drug responses, whereas 3D cardiac constructs fabricated by tissue engineering without a scaffold have high cell density and form intercellular interactions. This review summarizes the characteristics of scaffold-based and scaffold-free cardiac tissue engineering and discusses the applications of fabricated cardiac constructs to drug screening.
- 22 July 2021
- Published by IOP Publishing in Biofabrication
- Vol. 13 (4) , 042001
Scaffold-based and scaffold-free cardiac constructs for drug testing
The safety and therapeutic efficacy of new drugs are tested in experimental animals. However, besides being a laborious, costly process, differences in drug responses between humans and other animals and potential cardiac adverse effects lead to the discontinued development of new drugs. Thus, alternative approaches to animal tests are needed. Cardiotoxicity and responses of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to drugs are conventionally evaluated by cell seeding and two-dimensional (2D) culture, which allows measurements of field potential duration and the action potentials of CMs using multielectrode arrays. However, 2D-cultured hiPSC-CMs lack 3D spatial adhesion, and have fewer intercellular and extracellular matrix interactions, as well as different contractile behavior from CMs in vivo . This issue has been addressed using tissue engineering to fabricate three-dimensional (3D) cardiac constructs from hiPSC-CMs cultured in vitro . Tissue engineering can be categorized as scaffold-based and scaffold-free. In scaffold-based tissue engineering, collagen and fibrin gel scaffolds comprise a 3D culture environment in which seeded cells exhibit cardiac-specific functions and drug responses, whereas 3D cardiac constructs fabricated by tissue engineering without a scaffold have high cell density and form intercellular interactions. This review summarizes the characteristics of scaffold-based and scaffold-free cardiac tissue engineering and discusses the applications of fabricated cardiac constructs to drug screening.
- Open Access
- 2 June 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Drug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer
Cardiac constructs fabricated using human induced pluripotent stem cells-derived cardiomyocytes (iPSCs-CMs) are useful for evaluating the cardiotoxicity of and cardiac response to new drugs. Previously, we fabricated scaffold-free three-dimensional (3D) tubular cardiac constructs using a bio-3D printer, which can load cardiac spheroids onto a needle array. In this study, we developed a method to measure the contractile force and to evaluate the drug response in cardiac constructs. Specifically, we measured the movement of the needle tip upon contraction of the cardiac constructs on the needle array. The contractile force and beating rate of the cardiac constructs were evaluated by analysing changes in the movement of the needle tip. To evaluate the drug response, contractile properties were measured following treatment with isoproterenol, propranolol, or blebbistatin, in which the movement of the needle tip was increased following isoproterenol treatment, but was decreased following propranolol or blebbistain, treatments. To evaluate cardiotoxicity, contraction and cell viability of the cardiac constructs were measured following doxorubicin treatment. Cell viability was found to decrease with decreasing movement of the needle tip following doxorubicin treatment. Collectively, our results show that this method can aid in evaluating the contractile force of cardiac constructs.
- 2 June 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Open AccessDrug response analysis for scaffold-free cardiac constructs fabricated using bio-3D printer
Cardiac constructs fabricated using human induced pluripotent stem cells-derived cardiomyocytes (iPSCs-CMs) are useful for evaluating the cardiotoxicity of and cardiac response to new drugs. Previously, we fabricated scaffold-free three-dimensional (3D) tubular cardiac constructs using a bio-3D printer, which can load cardiac spheroids onto a needle array. In this study, we developed a method to measure the contractile force and to evaluate the drug response in cardiac constructs. Specifically, we measured the movement of the needle tip upon contraction of the cardiac constructs on the needle array. The contractile force and beating rate of the cardiac constructs were evaluated by analysing changes in the movement of the needle tip. To evaluate the drug response, contractile properties were measured following treatment with isoproterenol, propranolol, or blebbistatin, in which the movement of the needle tip was increased following isoproterenol treatment, but was decreased following propranolol or blebbistain, treatments. To evaluate cardiotoxicity, contraction and cell viability of the cardiac constructs were measured following doxorubicin treatment. Cell viability was found to decrease with decreasing movement of the needle tip following doxorubicin treatment. Collectively, our results show that this method can aid in evaluating the contractile force of cardiac constructs.